FDA Seeks Public Input on AI Medical Devices That Can Change Their Answers
OVERVIEWThe FDA is seeking public input on the regulation of AI medical devices that can change their answers over time — a category that includes continuously learning models and adaptive AI systems, according to Medical Daily. This solicitation reflects the agency's recognition that existing regulatory frameworks were not designed for devices whose behavior evolves after deployment. Traditional medical device regulation assumes a fixed device function: once cleared, the device performs the same function in the same way. AI devices that learn from new data or adapt their outputs based on feedback may effectively become different devices over time — potentially with different risk profiles — without triggering new regulatory review. The FDA's public input process is designed to gather stakeholder perspectives on how to address this challenge. Key questions likely being explored include: what types of changes to an AI device's behavior should require new pre-market review; how post-market surveillance should be structured to detect clinically meaningful changes in AI performance; and what transparency obligations device manufacturers should have when their AI models are updated. The outcome of this process is expected to inform forthcoming FDA guidance on adaptive AI devices. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.